Literature DB >> 22391813

Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.

Shengjie Zhang1, Tingting Jiang, Lifeng Feng, Jie Sun, Haiqi Lu, Qinchuan Wang, Min Pan, Dongsheng Huang, Xian Wang, Linbo Wang, Hongchuan Jin.   

Abstract

As a member of the GLI-Kruppel family of transcriptional factors, Yin Yang-1 (YY1) functions as an oncogene in various types of cancers. However, the role of YY1 in hepatocellular carcinogenesis remains unknown. In this report, we investigated the relevance of YY1 to hepatocellular carcinoma (HCC) development. We found that YY1 was upregulated in HCC cell lines. Ectopic YY1 expression promoted the growth of non-tumor liver cells that expressed low level of YY1. In contrast, YY1 depletion inhibited the growth of HCC cells which was accompanied with distinct morphological changes. Moreover, the phenotypic changes induced by YY1 depletion were attributed to cellular differentiation rather than cellular senescence. CCAAT/enhancer-binding protein alpha (CEBPA) which was important to regulate differentiation of hepatocytes was found as the direct target downregulated by YY1. Restoration of CEBPA in YY1-expressing HCC cells induced cellular differentiation and growth inhibition while knockdown of CEBPA expression in non-tumor liver cells promoted cell growth. In summary, our study demonstrated that YY1 could promote hepatocellular carcinogenesis and inhibit cellular differentiation through the downregulation of CEBPA expression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22391813     DOI: 10.1007/s00109-012-0879-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  29 in total

1.  CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.

Authors:  T-C Lin; H-A Hou; W-C Chou; D-L Ou; S-L Yu; H-F Tien; L-I Lin
Journal:  Leukemia       Date:  2010-10-07       Impact factor: 11.528

2.  Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Khelifa Arab; Rosemary E Teresi; Yasuhiro Tada; Charis Eng; Christoph Plass
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

3.  NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes.

Authors:  Huating Wang; Erin Hertlein; Nadine Bakkar; Hao Sun; Swarnali Acharyya; Jingxin Wang; Micheal Carathers; Ramana Davuluri; Denis C Guttridge
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

4.  YY1's longer DNA-binding motifs.

Authors:  Jeong do Kim; Joomyeong Kim
Journal:  Genomics       Date:  2008-11-08       Impact factor: 5.736

5.  Reduced expression of C/EBP alpha protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival.

Authors:  Hsi-Huang Tseng; Yaw-Huei Hwang; Kun-Tu Yeh; Jan-Gowth Chang; Yao-Li Chen; Hsin-Su Yu
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-29       Impact factor: 4.553

6.  Yin yang 1 modulates taxane response in epithelial ovarian cancer.

Authors:  Noriomi Matsumura; Zhiqing Huang; Tsukasa Baba; Paula S Lee; Jason C Barnett; Seiichi Mori; Jeffrey T Chang; Wen-Lin Kuo; Alison H Gusberg; Regina S Whitaker; Joe W Gray; Shingo Fujii; Andrew Berchuck; Susan K Murphy
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

Review 7.  The involvement of the transcription factor Yin Yang 1 in cancer development and progression.

Authors:  Giancarlo Castellano; Elena Torrisi; Giovanni Ligresti; Grazia Malaponte; Loredana Militello; Alessia E Russo; James A McCubrey; Silvana Canevari; Massimo Libra
Journal:  Cell Cycle       Date:  2009-05-26       Impact factor: 4.534

8.  NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma.

Authors:  Huating Wang; Ramiro Garzon; Hao Sun; Katherine J Ladner; Ravi Singh; Jason Dahlman; Alfred Cheng; Brett M Hall; Stephen J Qualman; Dawn S Chandler; Carlo M Croce; Denis C Guttridge
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

9.  Transcription factor YY1 expression in human gastrointestinal cancer cells.

Authors:  Dharmaraj Chinnappan; Dongmei Xiao; Anita Ratnasari; Chris Andry; Thomas C King; H Christian Weber
Journal:  Int J Oncol       Date:  2009-05       Impact factor: 5.650

10.  Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex.

Authors:  Chiung-Yuan Ko; Hey-Chi Hsu; Meng-Ru Shen; Wen-Chang Chang; Ju-Ming Wang
Journal:  J Biol Chem       Date:  2008-08-27       Impact factor: 5.157

View more
  16 in total

1.  A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel.

Authors:  Liqin Du; Robert Borkowski; Zhenze Zhao; Xiuye Ma; Xiaojie Yu; Xian-Jin Xie; Alexander Pertsemlidis
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

Review 2.  A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood.

Authors:  A R Lourenço; P J Coffer
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

3.  Histone deacetylase 3 inhibits new tumor suppressor gene DTWD1 in gastric cancer.

Authors:  Yanning Ma; Yongfang Yue; Min Pan; Jie Sun; Jue Chu; Xiaoying Lin; Wenxia Xu; Lifeng Feng; Yan Chen; Dingwei Chen; Vivian Y Shin; Xian Wang; Hongchuan Jin
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Opposing roles of C/EBPα and eEF1A1 in Sp1-regulated miR-122 transcription.

Authors:  Chunxian Zeng; Ye Sang; Feng-Yi Wang; Shi-Mei Zhuang
Journal:  RNA Biol       Date:  2019-10-07       Impact factor: 4.652

Review 5.  Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins.

Authors:  Sandy Leung-Kuen Au; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2013-04-26       Impact factor: 4.592

Review 6.  Zebrafish as a disease model for studying human hepatocellular carcinoma.

Authors:  Jeng-Wei Lu; Yi-Jung Ho; Yi-Ju Yang; Heng-An Liao; Shih-Ci Ciou; Liang-In Lin; Da-Liang Ou
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  YY1-MIR372-SQSTM1 regulatory axis in autophagy.

Authors:  Lifeng Feng; Yanning Ma; Jie Sun; Qi Shen; Leiming Liu; Haiqi Lu; Faliang Wang; Yongfang Yue; Jiaqiu Li; Shenjie Zhang; Xiaoying Lin; Jue Chu; Weidong Han; Xian Wang; Hongchuan Jin
Journal:  Autophagy       Date:  2014-06-11       Impact factor: 16.016

Review 8.  The Role of Transcription Factor YY1 in the Biology of Cancer.

Authors:  Neeraj Agarwal; Dan Theodorescu
Journal:  Crit Rev Oncog       Date:  2017

9.  The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis.

Authors:  Arman Shahrisa; Maryam Tahmasebi-Birgani; Hossein Ansari; Zahra Mohammadi; Vinicio Carloni; Javad Mohammadi Asl
Journal:  Mol Cytogenet       Date:  2021-07-02       Impact factor: 2.009

10.  Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4.

Authors:  H Lu; J Sun; F Wang; L Feng; Y Ma; Q Shen; Z Jiang; X Sun; X Wang; H Jin
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.